Nanoparticle based drug delivery system: milestone for cancer therapy. Journal of Biomedical and Pharmaceutical Research . 2012; 1 (2):1–6.A. S. Gousia Chashoo, Shashank Singh, Naveed A Qazi, "Nanoparticle Based Drug Delivery System: Milestone for Cancer Therapy," J. Biomed. Pharm. Res.,...
当当中华商务进口图书旗舰店在线销售正版《海外直订Nanoparticle-Based Drug Delivery in Cancer Treatment 基于纳米颗粒的药物递送在癌症治疗中的应用》。最新《海外直订Nanoparticle-Based Drug Delivery in Cancer Treatment 基于纳米颗粒的药物递送在癌症治疗中的应用》
分享到: 基于纳米粒子的药物输运方法 分类: 药学|查看相关文献(pubmed)|免费全文文献 详细解释: 以下为句子列表: 分享到:
Nanoparticle Drug Delivery 随着mRNA疫苗等基于纳米粒子的治疗方法的重要性和普及率不断提高,纳米药物的相关性也在不断加快。 为了高效地生产这些新型医疗产品,制药行业不得不重新评估过时的现有生产工艺,转而采用DIANT® Pharma创新的先进技术。 mRNA-LNP 技术 脂质纳米颗粒(LNPs)已成为纳米药物的优先考虑递送技术。...
Nanoparticle-based drug delivery systems improve therapeutic efficacy of cancer treatment. • Recent progresses of drug delivery systems based on chitosan, silica, and PLGA nanoparticles are discussed. • Development of multifunctional and targeting nanoparticles have the potential to further enhance thera...
In this review, nanoparticle-based drug delivery systems for delivering MET are summarized in the first part. The biomedical applications of these nanoparticle-based drug delivery systems are introduced in the following section. Finally, the combination therapy based on the drug delivery systems for ...
Nanoparticle-based combination therapy toward overcoming drug resistance in cancer Nanoparticle drug deliveryCancer treatmentThe use of multiple therapeutic agents in combination has become the primary strategy to treat drug resistant cancers... CMJ Hu,L Zhang - 《Biochemical Pharmacology》 被引量: 374发...
The use of nanoparticle-based drug delivery systems (DDSs) has an increasing impact on disease diagnosis and therapy. By altering their size, composition, and surface chemistry, nanoparticles can be developed into a universal platform with multifunctional capabilities to meet the tunable requirements of...
Nanoparticle-based drug delivery systems Nanoparticles are colloidal polymer particles of a size below 1 pm that are used as carriers for drugs as well as for vaccines. The drugs or antigens may be entrapped in the polymer matrix in particulate form or in the form of a solid so... J Kre...
over 80% of those candidates in drug pipeline are challenging to development due to their poor solubility and bioavailability.1There are several ocular barriers such as tear film, corneal, conjunctival and blood barriers that cause the bioavailability issues.2A nanotechnology-based dru...